108 related articles for article (PubMed ID: 9016602)
21. Allosteric inhibition of the DNA-dependent ATPase activity of Escherichia coli DNA gyrase by a representative of a novel class of inhibitors.
Shapiro AB; Andrews B
Biochem Pharmacol; 2012 Oct; 84(7):900-4. PubMed ID: 22820247
[TBL] [Abstract][Full Text] [Related]
22. Sites of preferred interaction between double-stranded pBR322 DNA and 7-methylpyrido[3,4-c]psoralen.
Chen JX; Kagan J
J Photochem Photobiol B; 1997 May; 39(1):56-62. PubMed ID: 9210322
[TBL] [Abstract][Full Text] [Related]
23. Fragment-based discovery of DNA gyrase inhibitors targeting the ATPase subunit of GyrB.
Mesleh MF; Cross JB; Zhang J; Kahmann J; Andersen OA; Barker J; Cheng RK; Felicetti B; Wood M; Hadfield AT; Scheich C; Moy TI; Yang Q; Shotwell J; Nguyen K; Lippa B; Dolle R; Ryan MD
Bioorg Med Chem Lett; 2016 Feb; 26(4):1314-8. PubMed ID: 26786695
[TBL] [Abstract][Full Text] [Related]
24. Expression in Escherichia coli of Y5-mutant and N-terminal domain-deleted DNA gyrase B proteins affects strongly plasmid maintenance.
Brino L; Mousli M; Oudet P; Weiss E
Plasmid; 1997; 38(3):188-201. PubMed ID: 9435021
[TBL] [Abstract][Full Text] [Related]
25. Base mutation analysis of topoisomerase II-idarubicin-DNA ternary complex formation. Evidence for enzyme subunit cooperativity in DNA cleavage.
Bigioni M; Zunino F; Capranico G
Nucleic Acids Res; 1994 Jun; 22(12):2274-81. PubMed ID: 8036155
[TBL] [Abstract][Full Text] [Related]
26. DNA cleavage is not required for the binding of quinolone drugs to the DNA gyrase-DNA complex.
Critchlow SE; Maxwell A
Biochemistry; 1996 Jun; 35(23):7387-93. PubMed ID: 8652515
[TBL] [Abstract][Full Text] [Related]
27. Pyrimido[1,6-a]benzimidazoles: a new class of DNA gyrase inhibitors.
Hubschwerlen C; Pflieger P; Specklin JL; Gubernator K; Gmünder H; Angehrn P; Kompis I
J Med Chem; 1992 Apr; 35(8):1385-92. PubMed ID: 1315393
[TBL] [Abstract][Full Text] [Related]
28. Site-specific interaction of DNA gyrase with DNA.
Fisher LM; Mizuuchi K; O'Dea MH; Ohmori H; Gellert M
Proc Natl Acad Sci U S A; 1981 Jul; 78(7):4165-9. PubMed ID: 6270661
[TBL] [Abstract][Full Text] [Related]
29. Mycobacterial DNA gyrase: enzyme purification and characterization of supercoiling activity.
Wu LC; Shahied SI
Arch Biochem Biophys; 1995 Dec; 324(1):123-9. PubMed ID: 7503546
[TBL] [Abstract][Full Text] [Related]
30. Highly sensitive mapping of
Morgan IL; McKie SJ; Kim R; Seol Y; Xu J; Harami G; Maxwell A; Neuman KC
bioRxiv; 2024 May; ():. PubMed ID: 38798569
[TBL] [Abstract][Full Text] [Related]
31. DNA gyrase binds to the family of prokaryotic repetitive extragenic palindromic sequences.
Yang Y; Ames GF
Proc Natl Acad Sci U S A; 1988 Dec; 85(23):8850-4. PubMed ID: 2848243
[TBL] [Abstract][Full Text] [Related]
32. Ciprofloxacin affects conformational equilibria of DNA gyrase A in the presence of magnesium ions.
Sissi C; Perdonà E; Domenici E; Feriani A; Howells AJ; Maxwell A; Palumbo M
J Mol Biol; 2001 Aug; 311(1):195-203. PubMed ID: 11469868
[TBL] [Abstract][Full Text] [Related]
33. Impact of mutations in DNA gyrase genes on quinolone resistance in Campylobacter jejuni.
Changkwanyeun R; Yamaguchi T; Kongsoi S; Changkaew K; Yokoyama K; Kim H; Suthienkul O; Usui M; Tamura Y; Nakajima C; Suzuki Y
Drug Test Anal; 2016 Oct; 8(10):1071-1076. PubMed ID: 26857529
[TBL] [Abstract][Full Text] [Related]
34. Contacts between DNA gyrase and its binding site on DNA: features of symmetry and asymmetry revealed by protection from nucleases.
Morrison A; Cozzarelli NR
Proc Natl Acad Sci U S A; 1981 Mar; 78(3):1416-20. PubMed ID: 6262797
[TBL] [Abstract][Full Text] [Related]
35. Effect of Qnr on Plasmid Gyrase Toxins CcdB and ParE.
Kwak YG; Jacoby GA; Hooper DC
Antimicrob Agents Chemother; 2015 Aug; 59(8):5078-9. PubMed ID: 26055367
[TBL] [Abstract][Full Text] [Related]
36. Ciprofloxacin dimers target gyrase in Streptococcus pneumoniae.
Gould KA; Pan XS; Kerns RJ; Fisher LM
Antimicrob Agents Chemother; 2004 Jun; 48(6):2108-15. PubMed ID: 15155208
[TBL] [Abstract][Full Text] [Related]
37. Sitafloxacin: antimicrobial activity against ciprofloxacin-selected laboratory mutants of Mycoplasma genitalium and inhibitory activity against its DNA gyrase and topoisomerase IV.
Deguchi T; Kikuchi M; Yasuda M; Ito S
J Infect Chemother; 2015 Jan; 21(1):74-5. PubMed ID: 25245990
[TBL] [Abstract][Full Text] [Related]
38. The antibiotic microcin B17 is a DNA gyrase poison: characterisation of the mode of inhibition.
Heddle JG; Blance SJ; Zamble DB; Hollfelder F; Miller DA; Wentzell LM; Walsh CT; Maxwell A
J Mol Biol; 2001 Apr; 307(5):1223-34. PubMed ID: 11292337
[TBL] [Abstract][Full Text] [Related]
39. Quinolones share a common interaction domain on topoisomerase II with other DNA cleavage-enhancing antineoplastic drugs.
Elsea SH; Westergaard M; Burden DA; Lomenick JP; Osheroff N
Biochemistry; 1997 Mar; 36(10):2919-24. PubMed ID: 9062121
[TBL] [Abstract][Full Text] [Related]
40. Short-range and long-range context effects on coliphage T4 endonuclease II-dependent restriction.
Carlson K; Kosturko LD; Nyström AC
J Bacteriol; 1996 Nov; 178(22):6419-26. PubMed ID: 8932296
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
